Thomas Wang Archives
Vanderbilt researchers to discuss heart disease, treatment at lecture
Sep. 17, 2015—Three Vanderbilt University researchers on the cutting edge of discovery will discuss the “human determinants of cardiovascular disease and treatment” during the next Flexner Discovery Lecture on Sept. 24.
Study team uses metabolomics to study longevity
Apr. 30, 2015—The keys to longevity have been a source of curiosity and the basis of many research studies for years, yet the mechanisms underlying a person’s ability to live a long life are still not fully understood.
Vitamin D found to have no impact on blood pressure
Feb. 19, 2015—Despite prior epidemiologic and experimental data to the contrary, new research shows that vitamin D supplementation does not reduce blood pressure in individuals with prehypertension or stage I hypertension and vitamin D deficiency.
Study finds few meet criteria for healthy cardiovascular lifestyle
Dec. 11, 2014—When it comes to taking care of our hearts, there is a big divide between what we should do and what we actually do, a new multi-institution study reports.
BioVU to collect plasma in hunt for heart failure clues
Nov. 6, 2014—Vanderbilt’s biobank, BioVU, has begun to collect and store plasma, the liquid part of blood, to aid studies of diseases ranging from heart failure and hypertension to breast cancer.
AHA grant creates coalition to prevent heart disease, stroke
Jul. 10, 2014—Vanderbilt University Medical Center is one of four institutions that are part of a new research network aimed at preventing heart disease and stroke, the two leading causes of death in the world.
Nine faculty honored with endowed chairs
Jan. 24, 2014—Nine Vanderbilt University faculty members named to endowed chairs were honored for their academic achievements during a celebration Jan. 22 at the Student Life Center.
Framingham Heart Study’s landmark impact examined
Oct. 3, 2013—While the Framingham Heart Study is often referenced throughout the halls of academia, few know its origin or can fully appreciate the contribution it has made to the understanding and prevention of cardiovascular disease.
Researchers identify novel biomarker for diabetes risk
Sep. 17, 2013—Researchers at the Vanderbilt Heart and Vascular Institute and Massachusetts General Hospital have identified a biomarker that can predict diabetes risk up to 10 years before onset of the disease.
Wang to lead Division of Cardiovascular Medicine
Apr. 18, 2013—Thomas Wang, M.D., has joined Vanderbilt as director of the Division of Cardiovascular Medicine and the physician-in-chief of the Vanderbilt Heart and Vascular Institute.
Cardiovascular Medicine chief Sawyer stepping down
Dec. 20, 2012—Doug Sawyer, M.D., Ph.D., Lisa M. Jacobson Chair of Cardiovascular Medicine and Professor of Medicine and Pharmacology, will step down as director of the Division of Cardiovascular Medicine and physician-in-chief of the Vanderbilt Heart and Vascular Institute (VHVI), effective April 1, 2013. Sawyer will continue to pursue his clinical, teaching and research endeavors at VHVI....
